Published by Abigail Townsend on 20th October 2021
(Sharecast News) - Biogen raised its full-year earnings guidance on Wednesday, despite weak sales of breakthrough Alzheimer's drug Aduhelm.
URL: http://www.digitallook.com/dl/news/story/32206080/...